NCT05441514 2025-09-16Enasidenib in Combination With Cobimetinib for the Treatment of Relapsed or Refractory Acute Myeloid LeukemiaCity of Hope Medical CenterPhase 1 Active not recruiting3 enrolled
NCT02632708 2025-04-11Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 MutationServierPhase 1 Active not recruiting153 enrolled